Background/Objectives: Inferior vena cava (IVC) filters are used to prevent pulmonary embolism (PE) in patients with contraindications to anticoagulation, among other indications. Despite clinical guidelines recommending timely retrieval, rates remain suboptimal, raising concerns about long-term complications. This study examines national hospital-level variation in IVC filter retrieval rates and adherence to timing recommendations. Methods: A retrospective analysis was conducted using data from 12,197 patients across 158 U.S. facilities between 1 January 2020, and 29 August 2024. Retrieval rates, time to retrieval, and associations with facility-specific factors such as procedural volume and academic affiliation were evaluated using descriptive statistics and correlation analyses. Results: Facility retrieval rates varied widely, ranging from 0.36% to 100%, with a mean of 23% (SD 24%). Only 43% (SD 12%) of filters were retrieved within 90 days, as recommended. A weak negative correlation was observed between retrieval rate and procedure volume (r = −0.24), as well as patient age (r = −0.17). Several high-volume facilities showed potential guideline non-adherence, placing many filters but retrieving few. No significant differences were found between academic and non-academic institutions in retrieval rate or timing. Conclusions: Substantial variability exists in IVC filter retrieval practices, and many facilities fall short of timely removal benchmarks. These findings highlight the need for targeted quality improvement initiatives to increase retrieval adherence, reduce filter-related complications, and improve patient outcomes.
18 September 2026 in Nuclear Medicine Communications
Objective: To determine whether qualitative technetium-99m sulfur colloid ( 99m Tc-SC) single-photon emission computed tomography/computed tomography (SPECT/CT) grading is discordant with conventional liver function assessment in patients undergoing preradioembolization evaluation. Methods: This single-center retrospective study included 96 consecutive patients who underwent dual-tracer 99m Tc-macroaggregated albumin and 99m Tc-SC SPECT/CT for yttrium-90 transarterial radioembolization planning. Sulfur colloid uptake was graded visually on a three-tier ordinal scale: grade I, normal; grade II, intermediate; and grade III, colloid shift. Contemporaneous laboratory values, Child–Pugh class, and model for end-stage liver disease score were recorded. Concordance was assessed using weighted kappa. Associations were evaluated with Spearman correlation, receiver operating characteristic analysis, and ordinal logistic regression. Results: Abnormal sulfur colloid findings, defined as grade II/III uptake, were present in 19 of 96 patients (19.8%), including eight patients (8.3%) with grade III colloid shift. Among 85 Child–Pugh A patients, 15 (17.6%) had abnormal sulfur colloid uptake; among 70 lab-normal patients, 11 (15.7%) had abnormal sulfur colloid uptake. Agreement between sulfur colloid grade and Child–Pugh class was poor (weighted kappa: 0.142). Higher sulfur colloid grade correlated modestly with albumin, total bilirubin, international normalized ratio, aspartate aminotransferase, and creatinine, but no variable remained independently associated after adjustment. Albumin best discriminated grade III shift [area under the curve (AUC): 0.732], whereas Child–Pugh class performed near chance (AUC: 0.511). Conclusion: Sulfur colloid SPECT/CT demonstrates reticuloendothelial distribution abnormalities in approximately one-fifth of preradioembolization patients, including some with preserved biochemical function. These discordant findings support further outcome-anchored evaluation of sulfur colloid SPECT/CT as a complementary tool before Y-90 radioembolization.